A Randomized, Placebo‐Controlled, Double‐Blind Phase III Trial Investigating the Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Using a Stringent Composite…

Overview of attention for article published in Dermatologic Surgery, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 7,964 followers.

BoNTA-INC RC 2xblind phase3 trial for glabellar frown lines using a stringent composite endpoint http://t.co/BZ9ZwawNI2 #Merz #Bocouture

RCT on Efficacy and Safety of IBoNT-A in the Treatment of GL Using a Stringent Composite Endpoint http://t.co/8OcXhKBEdU #Merz #Xeomin

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.